SCHEMBL8304975

SCHEMBL8304975

N#Cc1cccc(C(=O)c2ccc(N)cc2Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.47
GSK3B P49841 3/20 0.46
VNN1 O95497 8/20 0.45
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CLK1 P49759 1/20 0.41
DYRK1A Q13627 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
PBRM1 Q86U86 1/20 0.41
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194395 0.84 HSD17B10 (0.58) MAPK14MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL11710988 0.81 ALOX15 (0.52) MAPK14MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL6651723 0.79 GSK3B (0.53) MAPK14GSK3BVNN1CLK1DYRK1A
SCHEMBL5963546 0.79 MAPK13 (0.58) MAPK14MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL2199593 0.77 CYP3A4 (0.44) MAPK14SMN1; SMN2HSD17B10MAPK13MAPK12
SCHEMBL6772685 0.76 MAPK14 (0.48) MAPK14GSK3BVNN1CLK1DYRK1A
SCHEMBL5226711 0.75 MAPK14 (0.50) MAPK14GSK3BVNN1MAPTCLK1
SCHEMBL7183309 0.75 SRD5A2 (0.54) MAPK14MEN1MAPTKMT2ASMN1; SMN2
Chlorobenzene SCHEMBL27529703 0.75 MAPK14 (0.55) MAPK14MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL7090488 0.75 JAK2 (0.53) MEN1MAPTKMT2ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed